Kempharm Stock Price on March 9, 2021 Breakdown

KMPH -  USA Stock  

USD 10.75  0.24  2.18%

Kempharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings. As of today, the current price of Kempharm is  10.75 , as last reported on the 29th of July, with the highest price reaching  11.03  and the lowest price hitting  10.57  during the day.
Kempharm appears to be somewhat reliable, given 3 months investment horizon. Kempharm has Sharpe Ratio of 0.0724, which conveys that the firm had 0.0724% of return per unit of risk over the last 3 months. Our standpoint towards estimating the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Kempharm, which you can use to evaluate the future volatility of the firm. Please exercise Kempharm's Mean Deviation of 2.64, downside deviation of 3.77, and Risk Adjusted Performance of 0.0721 to check out if our risk estimates are consistent with your expectations.

Search Stock Price History 

The current Net Income Common Stock is estimated to decrease to about (13.8 M). Price to Book Value is estimated to decrease to -0.82. The current Price to Earnings Ratio is estimated to decrease to -3.76.

Kempharm Main Headline on 9th of March 2021

KemPharm to Report Fourth Quarter and Full Year 2020 Financial Results Yahoo Finance

Kempharm Valuation on March 9, 2021

It is possible to determine the worth of Kempharm on a given historical date. On March 9, 2021 Kempharm was worth 9.3 at the beginning of the trading date compared to the closed value of 9.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kempharm stock. Still, in general, we apply an absolute valuation method to find Kempharm's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kempharm's related companies.
 Open High Low Close Volume
  9.95    9.99    9.18    9.33    3,671,784  
  9.30    9.50    8.81    9.01    3,130,998  
  9.17    10.88    9.00    10.30    6,149,430  
Backtest Kempharm  |  Kempharm History  |  Kempharm Valuation   PreviousNext  
Open Value
9th of March 2021
Closing Value

Kempharm Trading Date Momentum on March 9, 2021

On March 10 2021 Kempharm was traded for  10.30  at the closing time. The top price for the day was 10.88  and the lowest listed price was  9.00 . The trading volume for the day was 6.1 M. The trading history from March 10, 2021 was a factor to the next trading day price rise. The trading delta at closing time against the next closing price was 14.32% . The trading delta at closing time against the current closing price is 18.42% .

Kempharm Fundamentals Correlations and Trends

By evaluating Kempharm's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kempharm's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kempharm financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Kempharm Stock history

Kempharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kempharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kempharm will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kempharm historical stock prices may prove useful in developing a viable investing in Kempharm
Last ReportedProjected for 2021
Weighted Average SharesM4.3 M
Weighted Average Shares DilutedM4.3 M
Issuance Purchase of Equity Shares25.6 M22.8 M
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company was incorporated in 2006 and is headquartered in Celebration, Florida. Kempharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.

Kempharm Quarterly Market Capitalization

261.06 MillionShare

Kempharm Stock Technical Analysis

Kempharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Kempharm technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kempharm trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Kempharm Period Price Range

March 9, 2021

Kempharm July 29, 2021 Market Strength

Market strength indicators help investors to evaluate how Kempharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kempharm shares will generate the highest return on investment. By undertsting and applying Kempharm stock market strength indicators, traders can identify Kempharm entry and exit signals to maximize returns

Kempharm Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Kempharm stock's direction in advance. Along with the technical and fundamental analysis of Kempharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kempharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please see Stocks Correlation. Note that the Kempharm information on this page should be used as a complementary analysis to other Kempharm's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Kempharm Stock analysis

When running Kempharm price analysis, check to measure Kempharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kempharm is operating at the current time. Most of Kempharm's value examination focuses on studying past and present price action to predict the probability of Kempharm's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kempharm's price. Additionally, you may evaluate how the addition of Kempharm to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
The market value of Kempharm is measured differently than its book value, which is the value of Kempharm that is recorded on the company's balance sheet. Investors also form their own opinion of Kempharm's value that differs from its market value or its book value, called intrinsic value, which is Kempharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kempharm's market value can be influenced by many factors that don't directly affect Kempharm underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kempharm's value and its price as these two are different measures arrived at by different means. Investors typically determine Kempharm value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kempharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.